{{Rsnum
|rsid=3784862
|Gene=ABCC1
|Chromosome=16
|position=16017034
|Orientation=plus
|GMAF=0.404
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=ABCC1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 60.2 | 34.5 | 5.3
| HCB | 13.1 | 42.3 | 44.5
| JPT | 10.6 | 45.1 | 44.2
| YRI | 49.0 | 40.8 | 10.2
| ASW | 45.6 | 40.4 | 14.0
| CHB | 13.1 | 42.3 | 44.5
| CHD | 16.5 | 42.2 | 41.3
| GIH | 15.8 | 62.4 | 21.8
| LWK | 40.0 | 45.5 | 14.5
| MEX | 32.8 | 55.2 | 12.1
| MKK | 27.6 | 53.2 | 19.2
| TSI | 51.0 | 38.2 | 10.8
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs3784862
|Name_s=
|Gene_s=ABCC1
|Feature=
|Evidence=PubMed ID:18256692
|Annotation=SNP is associated with the onset of toxicity to methotrexate in patients with psoriasis.
|Drugs=methotrexate
|Drug Classes=
|Diseases=Psoriasis
|Curation Level=Curated
|PharmGKB Accession ID=PA161149205
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3784862
|overall_frequency_n=81
|overall_frequency_d=128
|overall_frequency=0.632812
|n_genomes=46
|n_genomes_annotated=0
|n_haplomes=70
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}